top of page

Addressing Serious Mental Illness with VR, OxfordVR Earns FDA's Breakthrough Device Designation

  • OxfordVR's gameChange treats patients suffering from some of the most challenging Serious Mental Illness (SMI) conditions with automated Cognitive Behavioral Therapy

  • Fully automated and scalable, the platform helps solve the clinician shortage with an automated Virtual Therapist, and can be delivered with support from a wide-range of clinical staff and peer group members

  • Validated in a recent clinical trial, gameChange is more effective for patients than standard care alone; patients report a high degree of satisfaction and improvement in their quality of life



Addressing Serious Mental Illness with Virtual Reality, OxfordVR Earns FDA's Breakthrough Device Designation for its gameChange Treatment (prnewswire.com)

bottom of page